Edesa Biotech, Inc. Net Income Loss

• Edesa Biotech, Inc. showed a decrease of -16.5% in Net Income Loss from 2024 to 2025.
• This data is from Edesa Biotech, Inc.'s annual report (Form 10-K), filed with the SEC on December 12, 2025.
• XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 13 years of available data (2013 to 2025), Edesa Biotech, Inc.'s Net Income Loss has grown by 50.4%.
• Historical annual values: Fiscal year 2025: -$7.19 million | Fiscal year 2024: -$6.17 million | Fiscal year 2023: -$8.37 million | Fiscal year 2022: -$17.55 million | Fiscal year 2021: -$13.34 million | Fiscal year 2020: -$6.36 million | Fiscal year 2018: -$5.04 million | Fiscal year 2017: -$5.03 million | Fiscal year 2016: -$5.03 million | Fiscal year 2015: -$2.84 million | Fiscal year 2014: $1.13 million | Fiscal year 2014: -$8.44 million | Fiscal year 2013: -$14.50 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026